Medical school clears Kuklo of false-data charge
Committee finds former WU surgeon engaged in other misconduct
A Washington University committee has cleared former medical school researcher Timothy Kuklo of allegations that he falsified research in a military study, but found that he had engaged in other research misconduct.
Kuklo was under federal investigation after members of the U.S. Army accused him of fabricating data for a bone-growth drug study, which he performed at Walter Reed Army Medical Center in Washington, D.C. Now, a University committee says the claim that Kuklo made up data cannot be supported, though this does not mean he has been found innocent.
“This is akin to a finding of insufficient evidence, and should not be characterized as a complete exoneration,” the University said in a statement released Thursday.
The University committee found that Kuklo violated school research integrity policies and guidelines for human subject research in other ways.
History: Kuklo, Infuse and the University’s investigation
The committee’s findings come after seven months of investigation into Kuklo’s case.
Last spring, The New York Times printed allegations from several U.S. Army officials who claimed that Kuklo altered research data on Infuse, a bone-growth hormone used to treat wounded soldiers at Walter Reed.
The Army members alleged that Kuklo had inflated the number of soldiers with leg injuries who were able to be treated effectively with Infuse. Kuklo was also accused of forging the signatures of four Army doctors when submitting the results of his study for publication.
Controversy heightened around the case when it was revealed that Kuklo had been paid $800,000 by Medtronic, the company that makes Infuse. The University said later that Kuklo had not disclosed to the school his financial ties to Medtronic.
After the allegations surfaced, Kuklo took leave from the University in May. An article on his study was retracted from the medical journal that printed it. Sen. Chuck Grassley, R-Iowa, the ranking Republican on the Senate Finance Committee, began a federal inquiry into Kuklo’s case. Kuklo later resigned from the University.
A University committee was then formed to investigate the allegations brought against Kuklo.
The committee’s findings
Although the University’s full findings have not been made public, The New York Times reported Friday that the committee found it possible that Kuklo had not misrepresented the number of leg injuries that had been successfully treated with Infuse.
The committee based this conclusion on the assumption that Kuklo could have defined the leg injuries he studied more broadly than other Army officials would have. The committee also suggested that some of the questionable data tied to Kuklo could have resulted from problems with recordkeeping at Walter Reed.
But the committee found no justification for Kuklo’s forging four doctors’ signatures. The New York Times reported that Kuklo asserted he had only included the doctors’ names as a courtesy, but the committee determined that his forgeries suggested an “intentional deception.”
The University stated that it is not reconsidering Kuklo’s resignation in light of the committee’s findings.
University sharpens focus on research integrity
News of Kuklo’s clearing came at the end of the University’s inaugural Academic Integrity Week.
The week’s events, which culminated this weekend with the Center for Academic Integrity International Conference on campus, included several panel discussions and speakers on research integrity.
Last Monday, for example, student group Controversy N’ Coffee hosted a forum on cheating called, “Could my Wash. U. Degree Lose its Credibility?”
Tuesday saw a panel discussion on intellectual property law, and another panel was held Wednesday on integrity in job and graduate school applications.
On Thursday, David Callahan, public-policy activist and author of “The Cheating Culture” and “The Moral Center,” delivered an Assembly Series lecture titled, “Creating a Culture of Integrity.”